Researchers recently created detailed simulations on the Comet system at the San Diego Supercomputer Center showing how these stiff red blood cells flow through blood vessels, deforming and colliding along the way.
What happens when different strains of bacteria are present in the same system? Do they co-exist? Do the strongest survive? In a microbial game of rock-paper-scissors, researchers at the University of California San Diego’s BioCircuits Institute uncovered a surprising answer.
Compared to chimpanzees, our closest evolutionary cousins, humans are particularly prone to developing advanced carcinomas — the type of tumors that include prostate, breast, lung and colorectal cancers — even in the absence of known risk factors, such as genetic predisposition or tobacco use.
The San Diego Supercomputer Center at UC San Diego announced that its new Expanse supercomputer formally entered service for researchers following a program review by the National Science Foundation, which awarded SDSC a grant in mid-2019 to build the innovative system.
UC San Diego researchers used brain organoids to identify two drug candidates that counteract the genetic deficiencies that cause Rett syndrome, a rare form of autism spectrum disorder.
UC San Diego-led research is providing new details about honey bees and their defenses against preying hornets. Using a common iPad, James Nieh and his colleagues conducted the first study that demonstrates that a contagious warning signal counters “fake news” in social insects.
The California governor’s office today announced a statewide expansion to make CA Notify available to all Californians starting Thursday, December 10 in partnership with UC San Diego Health.
A team of SDSC researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19
Nanoengineers at UC San Diego have developed new and improved probes, known as positive controls, that could make it easier to validate rapid, point-of-care diagnostic tests for COVID-19 across the globe. The advance could help expand testing to low-resource, underserved areas.
University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.